Notably, of the clarifying questions for MSB are all generally about understanding mechanism etc rather than questioning data, or the null rate, or clinical trial design (FDA's concerns)
Ryoncil: ODAC/FDA Meeting Discussion, page-1104
-
- There are more pages in this discussion • 943 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.360M | 3.696M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 30486 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 14547 | 10 |
View Market Depth
| Last trade - 14.07pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |